Efficacy of Fish Oil on Serum TNFalpha, IL-1beta, IL-6, Oxidative Stress Markers in Multiple Sclerosis Treated With Interferon Beta 1-b

Trial Profile

Efficacy of Fish Oil on Serum TNFalpha, IL-1beta, IL-6, Oxidative Stress Markers in Multiple Sclerosis Treated With Interferon Beta 1-b

Completed
Phase of Trial: Phase IV

Latest Information Update: 21 May 2013

At a glance

  • Drugs Omega-3 carboxylic acids (Primary)
  • Indications Multiple sclerosis
  • Focus Pharmacodynamics
  • Acronyms EFOMS
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 08 May 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top